The discussion covers pivotal studies including:

  • REBOOT Trial.
  • BETAMIDAN Block.
  • DANGER Shock Trial.

Beyond trial data, the experts discuss the evolving role of shock centers, recent mechanical circulatory support (MCS) age analyses, and highlight what the Acute Cardiovascular Care Association (ACVC) is bringing to the field of cardiogenic shock – from research and guidelines to clinical implementation and continuous education.